{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T02:09:18Z","timestamp":1788487758757,"version":"build-2803163510"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["J Comput Assist Tomogr"],"published-print":{"date-parts":[[2021,7]]},"abstract":"<jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>Immunotherapy has emerged as a treatment option for head and neck squamous cell carcinoma (HNSCC), with tumor response being linked to the CD8+ T-cell inflammation. The purpose of this study is to assess whether computed tomography (CT) radiomic analysis can predict CD8+ T-cell enrichment in HNSCC primary tumors.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This retrospective study included 71 patients from a head and neck cancer genomics cohort with CD8+ T-cell enrichment status. Pretreatment contrast-enhanced neck CT scans were retrospectively reviewed using 3D Slicer for primary lesion segmentation.<\/jats:p>\n            <jats:p>The SlicerRadiomics extension was used to extract 107 radiomic features. Ridge regression and lasso regression were applied for feature selection and model construction.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Lasso regression defined Coarseness as the most important variable, followed by SmallDependenceEmphasis, SmallAreaLowGrayLevelEmphasis, Contrast.1, and Correlation.<\/jats:p>\n            <jats:p>Ridge regression defined Coarseness as the most important variable, followed by SmallDependenceLowGrayLevelEmphasis, Contrast.1, DependenceNonUniformityNormalized, and Idmn. These variables identified by lasso and ridge regressions were used to create a combined logistic regression model. The area under the curve (AUC) for the lasso-generated model was 0.786 (95% confidence interval [CI], 0.532\u20131.000), and the AUC for the ridge-generated model was 0.786 (95% CI, 0.544\u20131.000). Combining the radiomic variables identified by lasso and ridge regressions with clinical characteristics including alcohol use, tobacco use, anatomic site, and initial T stage produced a model with an AUC of 0.898 (95% CI, 0.731\u20131.000).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>T-cell inflammation status of HNSCC primary tumors can be predicted using radiomic analysis of CT imaging and thereby help identify patients who would respond well to immunotherapy.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/rct.0000000000001149","type":"journal-article","created":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T18:27:09Z","timestamp":1621448829000},"page":"629-636","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":21,"title":["Preliminary Computed Tomography Radiomics Model for Predicting Pretreatment CD8+ T-Cell Infiltration Status for Primary Head and Neck Squamous Cell Carcinoma"],"prefix":"10.1097","volume":"45","author":[{"given":"Colin Y.","family":"Wang","sequence":"first","affiliation":[{"name":"Pritzker School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Thomas","family":"Ginat","sequence":"additional","affiliation":[{"name":"Department of Radiology, The University of Chicago, Chicago, IL."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"bib1-20250802","first-page":"e89829","article-title":"The head and neck cancer immune landscape and its immunotherapeutic implications","volume":"1","journal-title":"JCI Insight"},{"key":"bib3-20250802","first-page":"7497","article-title":"Application of molecular targeted therapies in the treatment of head and neck squamous cell carcinoma","volume":"15","year":"2018","journal-title":"Oncol Lett"},{"key":"bib4-20250802","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/s41416-018-0131-9","article-title":"Efficacy and safety of pembrolizumab in recurrent\/metastatic head and neck squamous cell carcinoma: pooled analyses after long-term follow-up in KEYNOTE-012","volume":"119","year":"2018","journal-title":"Br J Cancer"},{"key":"bib5-20250802","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1158\/2326-6066.CIR-18-0277","article-title":"T cell\u2013inflamed versus non\u2013T cell\u2013inflamed tumors: a conceptual framework for cancer immunotherapy drug development and combination therapy selection","volume":"6","year":"2018","journal-title":"Cancer Immunol Res"},{"key":"bib6-20250802","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.it.2015.02.003","article-title":"The STING pathway and the T cell\u2013inflamed tumor microenvironment","volume":"36","year":"2015","journal-title":"Trends Immunol"},{"key":"bib7-20250802","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1158\/1078-0432.CCR-15-1507","article-title":"The where, the when, and the how of immune monitoring for cancer immunotherapies in the era of checkpoint inhibition","volume":"22","year":"2016","journal-title":"Clin Cancer Res"},{"key":"bib8-20250802","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1158\/0008-5472.CAN-15-1707","article-title":"An effective immuno-PET imaging method to monitor CD8-dependent responses to immunotherapy","volume":"76","year":"2016","journal-title":"Cancer Res"},{"key":"bib9-20250802","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1093\/annonc\/mdz108","article-title":"Predicting response to cancer immunotherapy using noninvasive radiomic biomarkers","volume":"30","year":"2019","journal-title":"Ann Oncol"},{"key":"bib10-20250802","doi-asserted-by":"crossref","first-page":"46349","DOI":"10.1038\/srep46349","article-title":"Radiomics-based prognosis analysis for non\u2013small cell lung cancer","volume":"7","year":"2017","journal-title":"Sci Rep"},{"key":"bib11-20250802","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3174\/ajnr.A4110","article-title":"MRI texture analysis predicts p53 status in head and neck squamous cell carcinoma","volume":"36","year":"2015","journal-title":"AJNR Am J Neuroradiol"},{"key":"bib12-20250802","doi-asserted-by":"crossref","first-page":"399","DOI":"10.21037\/qims.2019.03.08","article-title":"Prognostic value of pre-treatment CT texture analysis in combination with change in size of the primary tumor in response to induction chemotherapy for HPV-positive oropharyngeal squamous cell carcinoma","volume":"9","year":"2019","journal-title":"Quant Imaging Med Surg"},{"key":"bib13-20250802","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/S1470-2045(18)30413-3","article-title":"A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study","volume":"19","year":"2018","journal-title":"Lancet Oncol"},{"key":"bib14-20250802","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.oraloncology.2019.06.032","article-title":"Immune profiles in primary squamous cell carcinoma of the head and neck","volume":"96","year":"2019","journal-title":"Oral Oncol"},{"key":"bib15-20250802","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/srep00765","article-title":"12-Chemokine gene signature identifies lymph node-like structures in melanoma: potential for patient selection for immunotherapy?","volume":"2","year":"2012","journal-title":"Sci Rep"},{"key":"bib16-20250802","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1158\/0008-5472.CAN-08-2281","article-title":"Chemokine expression in melanoma metastases associated with CD8+ T-cell recruitment","volume":"69","year":"2009","journal-title":"Cancer Res"},{"key":"bib17-20250802","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1158\/1078-0432.CCR-14-2481","article-title":"Integrative analysis of head and neck cancer identifies two biologically distinct HPV and three non-HPV subtypes","volume":"21","year":"2015","journal-title":"Clin Cancer Res"},{"key":"bib18-20250802","doi-asserted-by":"crossref","first-page":"e104","DOI":"10.1158\/0008-5472.CAN-17-0339","article-title":"Computational radiomics system to decode the radiographic phenotype","volume":"77","year":"2017","journal-title":"Cancer Res"},{"key":"bib19-20250802","first-page":"1856","article-title":"Nivolumab for recurrent squamous-cell carcinoma of the head and neck","volume":"75","year":"2016","journal-title":"N Engl J Med [Internet]"},{"key":"bib20-20250802","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0140-6736(18)31999-8","article-title":"Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study","volume":"393","year":"2019","journal-title":"Lancet"},{"key":"bib21-20250802","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/s41577-018-0044-0","article-title":"CD4 + T cell help in cancer immunology and immunotherapy","volume":"18","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"bib22-20250802","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/nature13954","article-title":"PD-1 blockade induces responses by inhibiting adaptive immune resistance","volume":"515","year":"2014","journal-title":"Nature"},{"key":"bib23-20250802","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nrc.2017.117","article-title":"Impact of oncogenic pathways on evasion of antitumour immune responses","volume":"18","year":"2018","journal-title":"Nat Rev Cancer"},{"key":"bib24-20250802","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.3390\/cancers11091398","article-title":"CD8+ and regulatory T cells differentiate tumor immune phenotypes and predict survival in locally advanced head and neck cancer","volume":"11","year":"2019","journal-title":"Cancers (Basel)"},{"key":"bib25-20250802","doi-asserted-by":"crossref","first-page":"4537","DOI":"10.1245\/s10434-019-07815-9","article-title":"Preoperative radiomic approach to evaluate tumor-infiltrating CD8+ T cells in hepatocellular carcinoma patients using contrast-enhanced computed tomography","volume":"26","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"bib26-20250802","doi-asserted-by":"crossref","first-page":"104877","DOI":"10.1016\/j.oraloncology.2020.104877","article-title":"Radiomic analysis identifies tumor subtypes associated with distinct molecular and microenvironmental factors in head and neck squamous cell carcinoma","volume":"110","year":"2020","journal-title":"Oral Oncol"},{"key":"bib27-20250802","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1093\/jnci\/djy060","article-title":"Tobacco smoking-associated alterations in the immune microenvironment of squamous cell carcinomas","volume":"110","year":"2018","journal-title":"J Natl Cancer Inst"},{"key":"bib28-20250802","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1109\/21.44046","article-title":"Textural features corresponding to textural properties","volume":"19","year":"1989","journal-title":"IEEE Trans Syst Man Cybern"},{"key":"bib29-20250802","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1007\/s00259-019-04372-x","article-title":"Towards clinical application of image mining: a systematic review on artificial intelligence and radiomics","volume":"46","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib30-20250802","doi-asserted-by":"crossref","first-page":"e1498439","DOI":"10.1080\/2162402X.2018.1498439","article-title":"Treatment-na\u00efve HPV+ head and neck cancers display a T-cell\u2013inflamed phenotype distinct from their HPV\u2212 counterparts that has implications for immunotherapy","volume":"7","year":"2018","journal-title":"Oncoimmunology"},{"key":"bib31-20250802","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1158\/1078-0432.CCR-13-3310","article-title":"Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas","volume":"21","year":"2015","journal-title":"Clin Cancer Res"},{"key":"bib32-20250802","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12957-020-1792-4","article-title":"Smokers or non-smokers: who benefits more from immune checkpoint inhibitors in treatment of malignancies? An up-to-date meta-analysis","volume":"18","year":"2020","journal-title":"World J Surg Oncol"},{"key":"bib33-20250802","doi-asserted-by":"crossref","first-page":"5546","DOI":"10.1038\/s41467-019-13471-0","article-title":"Syngeneic animal models of tobacco-associated oral cancer reveal the activity of in situ anti\u2013CTLA-4","volume":"10","year":"2019","journal-title":"Nat Commun"}],"container-title":["Journal of Computer Assisted Tomography"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RCT.0000000000001149","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T23:21:43Z","timestamp":1754176903000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RCT.0000000000001149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/rct.0000000000001149","relation":{},"ISSN":["1532-3145","0363-8715"],"issn-type":[{"value":"1532-3145","type":"electronic"},{"value":"0363-8715","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]}}}